Utilization of Direct Acting Oral Anticoagulants in Patients with Liver Cirrhosis: Is It Safe?: (CTGH) - Lupine Publishers

Utilization of Direct Acting Oral Anticoagulants in Patients with Liver Cirrhosis: Is It Safe? by Saad Qadwai in Current Trends in Gastroenterology and Hepatology (CTGH) in Lupine Publishers

Patients with liver cirrhosis are known to have increased risk bleeding particularly from gastrointestinal tract. However, recent literature has shown that patients with liver cirrhosis are also at increased risk of thrombotic complications. Therefore, it is important to consider anticoagulation in cirrhotic patients. The purpose of this article is to review the epidemiological studies available in scientific literature comparing the risk of bleeding in cirrhotic patients utilizing DOACs vs traditional anticoagulation.

http://www.lupinepublishers.com/ctgh/fulltext/CTGH.MS.ID.000106.php

http://www.lupinepublishers.com/ctgh/pdf/CTGH.MS.ID.000106.pdf

http://www.lupinepublishers.com/ctgh/abstracts/CTGH.MS.ID.000106.php